FindTrial
Sign In

Competative study of letrozole and clomiphene citrate verses letrozole alone in ovarian stimulation

A randomised controlled trial comparing combination of letrozole and clomiphene citrate or letrozole alone for ovarian stimulation in infertile women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050914
Enrollment
180
Registered
2023-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Combination of the drugs: To increase efficacy, use of 2 drugs with different mechanisms of action Intervention2: Tab letrozole and tab clomiphene citrate: Tab letrozole 5 mg Tab clomip

Sponsors

No sponser is required
Lead Sponsor
No sponser required
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Female with anovulatory cycle

Exclusion criteria

Exclusion criteria: 1.Woman not giving consent 2.current hormonal contraception use 3.other known cause of infertility (tubal factor) 4.uncorrected thyroid disease 5.untreated hyperprolactinemia 6.medical conditions not well controlled or not recommended during pregnancy ( uncontrolled type 1 and type 2 diabetes mellitus, hypertension, endometrial hyperplasia/cancer

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed by TVS Scan , ovarian stimulation and follicles have been formed or notTimepoint: 1 cycle—

Secondary

MeasureTime frame
FertilityTimepoint: 1 year—

Countries

India

Contacts

Public ContactAnamika Kumari

Kings George medical College

monaasnani@kgmcindia.edu8808241222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026